Completed
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
NCT01850238
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- Univeristätsklinik für Neurologie, PMU, Christian-Doppler Klinik Salzburg, State of Salzburg, Austria
- Medizinische Universitat Wien Vienna, State of Vienna, Austria
- Medizinische Universitat Graz Graz, Styria, Austria